id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2001-D-0137-0010,FDA,FDA-2001-D-0137,FDA,Notice,NAD-Notice of Availability of Data,2007-03-06T05:00:00Z,2007,3,2007-03-05T05:00:00Z,,2008-04-25T02:25:55Z,,0,0,09000064804ddb14
FDA-2001-D-0137-0012,FDA,FDA-2001-D-0137,Guidance,Supporting & Related Material,GDL-Guidance,2007-03-06T05:00:00Z,2007,3,,,2008-04-25T02:25:55Z,,0,0,09000064804ddb16
FDA-2001-D-0137-0011,FDA,FDA-2001-D-0137,Guidance for Industry; Orally Inhaled and Intranasal Corticosteroids: Evaluation of the Effects on Growth in Children,Other,Guidance,2007-03-05T05:00:00Z,2007,3,2007-03-05T05:00:00Z,,2024-11-07T21:53:19Z,,1,0,09000064804ddb15